RASAGILINE FOR PARKINSON'S DISEASE MODIFICATION

A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GOREN TAMAR, SAYAG NAIM, WEISS YONATAN, EYAL ELI, BEN-AMI MIRI, OREN SHEILA, LEVY RUTH
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GOREN TAMAR
SAYAG NAIM
WEISS YONATAN
EYAL ELI
BEN-AMI MIRI
OREN SHEILA
LEVY RUTH
description A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression; delaying the need for symptomatic anti-Parkinsonian therapy; reducing the risk of a Parkinson's disease patient requiring symptomatic anti-Parkinsonian therapy; and reducing the functional decline.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2014243418A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2014243418A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2014243418A13</originalsourceid><addsrcrecordid>eNrjZNAPcgx2dPf08fRzVXDzD1IIcAzy9vQL9vdTD1Zw8Qx2dQx2VfD1d_F083R2DPH09-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhiZGJsYmhhaOhsbEqQIAn60m7Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RASAGILINE FOR PARKINSON'S DISEASE MODIFICATION</title><source>esp@cenet</source><creator>GOREN TAMAR ; SAYAG NAIM ; WEISS YONATAN ; EYAL ELI ; BEN-AMI MIRI ; OREN SHEILA ; LEVY RUTH</creator><creatorcontrib>GOREN TAMAR ; SAYAG NAIM ; WEISS YONATAN ; EYAL ELI ; BEN-AMI MIRI ; OREN SHEILA ; LEVY RUTH</creatorcontrib><description>A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression; delaying the need for symptomatic anti-Parkinsonian therapy; reducing the risk of a Parkinson's disease patient requiring symptomatic anti-Parkinsonian therapy; and reducing the functional decline.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140828&amp;DB=EPODOC&amp;CC=US&amp;NR=2014243418A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140828&amp;DB=EPODOC&amp;CC=US&amp;NR=2014243418A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOREN TAMAR</creatorcontrib><creatorcontrib>SAYAG NAIM</creatorcontrib><creatorcontrib>WEISS YONATAN</creatorcontrib><creatorcontrib>EYAL ELI</creatorcontrib><creatorcontrib>BEN-AMI MIRI</creatorcontrib><creatorcontrib>OREN SHEILA</creatorcontrib><creatorcontrib>LEVY RUTH</creatorcontrib><title>RASAGILINE FOR PARKINSON'S DISEASE MODIFICATION</title><description>A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression; delaying the need for symptomatic anti-Parkinsonian therapy; reducing the risk of a Parkinson's disease patient requiring symptomatic anti-Parkinsonian therapy; and reducing the functional decline.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPcgx2dPf08fRzVXDzD1IIcAzy9vQL9vdTD1Zw8Qx2dQx2VfD1d_F083R2DPH09-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhiZGJsYmhhaOhsbEqQIAn60m7Q</recordid><startdate>20140828</startdate><enddate>20140828</enddate><creator>GOREN TAMAR</creator><creator>SAYAG NAIM</creator><creator>WEISS YONATAN</creator><creator>EYAL ELI</creator><creator>BEN-AMI MIRI</creator><creator>OREN SHEILA</creator><creator>LEVY RUTH</creator><scope>EVB</scope></search><sort><creationdate>20140828</creationdate><title>RASAGILINE FOR PARKINSON'S DISEASE MODIFICATION</title><author>GOREN TAMAR ; SAYAG NAIM ; WEISS YONATAN ; EYAL ELI ; BEN-AMI MIRI ; OREN SHEILA ; LEVY RUTH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2014243418A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GOREN TAMAR</creatorcontrib><creatorcontrib>SAYAG NAIM</creatorcontrib><creatorcontrib>WEISS YONATAN</creatorcontrib><creatorcontrib>EYAL ELI</creatorcontrib><creatorcontrib>BEN-AMI MIRI</creatorcontrib><creatorcontrib>OREN SHEILA</creatorcontrib><creatorcontrib>LEVY RUTH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOREN TAMAR</au><au>SAYAG NAIM</au><au>WEISS YONATAN</au><au>EYAL ELI</au><au>BEN-AMI MIRI</au><au>OREN SHEILA</au><au>LEVY RUTH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RASAGILINE FOR PARKINSON'S DISEASE MODIFICATION</title><date>2014-08-28</date><risdate>2014</risdate><abstract>A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression; delaying the need for symptomatic anti-Parkinsonian therapy; reducing the risk of a Parkinson's disease patient requiring symptomatic anti-Parkinsonian therapy; and reducing the functional decline.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2014243418A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title RASAGILINE FOR PARKINSON'S DISEASE MODIFICATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A25%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOREN%20TAMAR&rft.date=2014-08-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2014243418A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true